查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1864212

生物样品处理市场按产品类型、最终用户、应用、样品类型和工作流程划分－2025-2032年全球预测

Biological Sample Handling Market by Product Type, End User, Application, Sample Type, Workflow - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，生物样本处理市场规模将达到 331.6 亿美元，复合年增长率为 6.62%。

关键市场统计数据
基准年 2024 198.5亿美元
预计年份：2025年 211.9亿美元
预测年份 2032 331.6亿美元
复合年增长率 (%) 6.62%

概述营运重点、品质压力和跨职能决策需求，以建立生物样本处理的策略架构。

现代生物样本处理生态系统融合了科学严谨性、营运效率和严格的监管。实验室、临床机构、研究中心和工业研发团队面临日益增长的样本完整性维护要求，涵盖从采集到分析的整个过程。自动化、数位化和试剂化学的进步正在改变日常工作流程，而对可重复性和可追溯性的日益增长的需求则要求更严格的流程控制和检验的供应链。

透过自动化、试剂创新和数据驱动的监管链解决方案，展现检体处理方式的变革性转变。

生物样本处理领域正经历着一场变革性的转变，其驱动力包括技术成熟、监管机构对资料完整性的重视以及临床和科学研究终端使用者不断变化的需求。自动化已从独立仪器发展到整合采集、处理和储存功能的流程平台，使检查室能够在提高通量的同时减少人为错误。试剂配方和试剂盒设计的同步进步正在提高各种检测方法的稳定性和相容性，降低变异性并缩短检验时间。

评估2025年实施的关税对检查室采购、供应商策略和供应链韧性的累积营运和采购影响

2025年实施的新关税措施增加了支持生物样本处理的全球供应链的复杂性，影响了筹资策略和营运计画。进口实验室设备、耗材和某些试剂类别的关税调整增加了依赖跨境采购的机构的到岸成本，迫使采购部门重新评估供应商选择和库存管理政策。为此，许多机构正在修订其总体拥有成本 (TCO) 计算方法，以反映关税、更长的前置作业时间和增加的物流风险。

整合产品、最终用户、应用、检体类型和工作流程等因素，这些因素共同驱动采购和检验的优先事项，从而提供可操作的细分洞察。

对细分市场的详细分析揭示了产品类型、最终用户、应用、样本类型和工作流程如何影响样本处理过程中的采购优先顺序和创新应用。检验产品类型发现，耗材、仪器、试剂和试剂盒以及软体和服务各自对买家有不同的价值提案。在仪器领域，随着实验室追求更高的通量和可重复性，自动移液系统、温控离心机和涡旋搅拌机的需求显着。同时，包括抗体、缓衝液和溶液、酵素以及标记和检测试剂在内的试剂和试剂盒，对检测性能和相容性起着决定性作用。最终用户的多样性影响着采购行为。学术研究机构、生物製药公司、合约研究组织 (CRO)、受託研究机构检查室和医院在检验、通量和成本控制方面采用不同的标准。特别是诊断检查室，又细分为临床化学、血液学、微生物学和分子诊断，每个领域都有其独特的处理要求。

了解美洲、欧洲、中东和非洲以及亚太地区的区域管理体制、製造能力和物流基础设施如何创造不同的机会。

区域趋势正在影响检体处理的策略选择，各机构在评估当地法规结构、製造地和物流基础设施时都会做出相应调整。在美洲，需求模式反映了高通量临床检查室和生物製药研发中心的多元化组合，这些机构优先考虑自动化、长期供应商关係以及快速获取新型试剂。供应链整合和大规模合约服务供应商的存在进一步影响供应商的选择和首选的商业模式。

识别供应商之间的竞争差异化因素，这些因素结合了检验的产品系列、服务模式和互通性，以减少分析前变异性。

在样本处理生态系统中，竞争格局日益取决于企业提供涵盖硬体、耗材、试剂和资讯服务的一体化提案主张的能力。拥有完善的品质系统、法规支援和清晰检验文件的供应商通常更受受监管的终端用户青睐，而拥有模组化、可互通平台的供应商则更受高通量研究和工业客户的青睐。投资于特定应用试剂盒、试剂和检验通讯协定的公司能够降低采用门槛并提高客户维繫，尤其是在诊断流程和受监管的药物开发工作流程中。

为增强供应链韧性、规范验证流程和提高自动化程度以降低分析前风险和营运风险，提出切实可行的建议

透过协调筹资策略、验证计画和跨职能管治，产业领导者可以即时采取切实可行的措施来加强其检体处理流程。首先，建立严格的供应商选择流程，评估批次间一致性文件、试剂稳定性数据和耗材可追溯性，并确保合约涵盖关税和物流风险。其次，优先投资自动化，以显着减少人为错误并实现稳定的处理量，并将这些投资与培训计划相结合，使检查室人员能够有效地操作和维护自动化系统。

我们描述了一种严谨的混合方法调查方法，该方法结合了初步访谈、技术文献综述和专家检验，以确保研究结果的可操作性和准确性。

本研究途径结合了结构化的初步研究和针对性的二次研究，旨在对生物样本处理动态进行稳健且基于证据的评估。初步研究包括对实验室主任、采购人员、品质保证专业人员和供应链经理进行访谈，以收集有关挑战、推广驱动因素和检验障碍的第一手资讯。这些访谈旨在了解操作细节，例如工作流程瓶颈、试剂稳定性问题和仪器运转率优先事项，并且所有访谈均匿名保密，以鼓励受访者坦诚作答。

最后，报告清楚地总结瞭如何透过协调投资自动化、检验的试剂和可靠的采购管道来确保检体完整性和业务连续性。

摘要，生物样本处理领域正处于转折点，技术创新、监管审查和供应链趋势相互交织，重新定义检查室保护检体完整性和加速发现的方式。积极投资于可互通自动化系统、检验的试剂系统和即时监管链监控的机构，将能够更好地应对分析前变异性和合规性要求。同样重要的是，鑑于关税压力和物流不确定性，对采购惯例实践进行策略性重组，从而建立多元化的供应商组合和强大的区域伙伴关係关係。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 采用一次性生物製程技术，最大限度地减少生物製药生产的交叉污染
  • 推出支援物联网的低温运输监控设备，用于即时追踪整个供应链中的样品完整性
  • 随着分散式就地检验的普及，需要可靠的样本稳定和运输解决方案。
  • 透过使用新型冷冻保护剂开发冷冻保存方法来改善长期储存。
  • 实验室自动化平台的发展，融合了人工智慧驱动的品管，用于样品处理和数据管理。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的生物样品处理市场

  • 消耗品
  • 装置
    • 自动化移液系统
    • 温控离心机
    • 涡流搅拌机
  • 试剂和试剂盒
    • 抗体
    • 缓衝液和溶液
    • 酵素
    • 标记和检测试剂
  • 软体和服务

9. 依最终使用者分類的生物样品处理市场

  • 学术研究机构
  • 生物製药公司
  • CRO（受託研究机构）
  • 诊断检查室
    • 临床化学
    • 血液学
    • 微生物学
    • 分子诊断
  • 医院

第十章 生物工具处理市场（按应用领域划分）

  • 诊断
    • 实验室测试
    • 护理点
  • 药物发现与开发
  • 基因组学
  • 蛋白质体学

第十一章 生物样本处理市场（按样品类型划分）

  • 血
  • 细胞
  • 组织
  • 尿

12. 依工作流程分類的生物样本处理市场

  • 分析
  • 收藏
  • 过程
  • 贮存
  • 运输

13. 各地区生物样品处理市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 生物工具处理市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国生物样本处理市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Avantor, Inc.
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.
    • Sartorius AG
    • QIAGEN NV
    • General Electric Company
Product Code: MRR-757B1C9CB0B6

The Biological Sample Handling Market is projected to grow by USD 33.16 billion at a CAGR of 6.62% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 19.85 billion
Estimated Year [2025] USD 21.19 billion
Forecast Year [2032] USD 33.16 billion
CAGR (%) 6.62%

Establishing the strategic context for biological sample handling by outlining operational priorities, quality pressures, and cross-functional decision imperatives

The contemporary ecosystem for biological sample handling sits at the intersection of scientific rigor, operational efficiency, and stringent regulatory oversight. Laboratories, clinical facilities, research centers, and industrial R&D teams face an expanding set of requirements to preserve sample integrity from collection through analysis. Advances in automation, digitization, and reagent chemistry are reshaping daily workflows, while heightened expectations around reproducibility and traceability demand tighter process controls and validated supply chains.

Against this backdrop, organizations must balance cost pressures with the imperative to minimize pre-analytical variability. Investments in instrumentation, consumables, and end-to-end workflow solutions increasingly reflect a strategic choice to reduce downstream assay failures and accelerate time to insight. As practices evolve, cross-functional collaboration among procurement, laboratory operations, quality, and informatics becomes vital to ensure that equipment selection, reagent sourcing, and storage protocols collectively support scientific objectives without introducing unmanageable complexity. This introduction frames the primary forces influencing decision-making and sets the stage for deeper analysis of technological shifts, policy impacts, and segmentation-specific dynamics that follow.

Mapping the transformative shifts reshaping sample handling through automation, reagent innovation, and data-driven chain-of-custody solutions

The landscape of biological sample handling is undergoing transformative shifts driven by technological maturation, regulatory emphasis on data integrity, and changing demand patterns from both clinical and research end users. Automation is moving beyond isolated instruments to integrated workflow platforms that combine collection, processing, and storage functions, enabling labs to scale throughput while reducing human error. Parallel advances in reagent formulations and kit design are improving stability and compatibility across diverse assay modalities, which in turn reduces variability and shortens validation timelines.

Data-centric approaches are becoming central; laboratory informatics systems and connected devices now enable real-time monitoring of sample chain-of-custody and environmental conditions. This connectivity supports risk-based quality management and allows organizations to detect and remediate deviations more quickly. Additionally, there is an increasing premium on modular solutions that can be configured to meet both high-throughput industrial needs and smaller, decentralized clinical settings. Taken together, these trends are reshaping procurement priorities, incentivizing scalable investments, and redefining the vendor landscape as suppliers compete to offer interoperable, validated systems that span multiple steps of the sample lifecycle.

Assessing the cumulative operational and sourcing impacts of tariff measures introduced in 2025 on laboratory procurement, supplier strategies, and supply chain resilience

The advent of new tariff measures in 2025 has introduced a layer of complexity to global supply chains that support biological sample handling, affecting procurement strategies and operational planning. Tariff adjustments on imported laboratory equipment, consumables, and certain reagent categories have increased landed costs for organizations that rely on cross-border sourcing, prompting procurement teams to re-evaluate supplier selection and inventory policies. In response, many organizations are revisiting total cost of ownership calculations to reflect duties, longer lead times, and elevated logistics risk.

Consequently, buyers are exploring alternatives such as nearshoring, supplier diversification, and longer-term contracts to mitigate exposure to tariff volatility. These approaches generally emphasize building relationships with regional manufacturers and distributors, qualifying secondary suppliers to maintain continuity, and increasing buffer inventories for critical items. Regulatory-driven requirements for validated supply chains and traceability further complicate substitution decisions, creating tension between cost mitigation and compliance. Overall, the cumulative impact of the tariffs is accelerating strategic shifts toward more resilient sourcing models, greater supply chain transparency, and heightened collaboration between procurement and laboratory operations to balance affordability with uninterrupted access to validated materials and equipment.

Delivering practical segmentation insights by synthesizing product, end user, application, sample type, and workflow drivers that determine procurement and validation priorities

A nuanced view of segmentation reveals how product type, end user, application, sample type, and workflow each shape procurement priorities and innovation adoption across the sample handling continuum. Examining product type shows that consumables, instruments, reagents and kits, and software and services occupy distinct value propositions to buyers; within instruments there is a pronounced demand for automated pipetting systems, temperature-controlled centrifuges, and vortex mixers as laboratories seek throughput gains and reproducibility, while reagents and kits such as antibodies, buffers and solutions, enzymes, and labeling and detection reagents drive assay performance and compatibility. End user diversity affects purchasing behavior, as academic and research institutes, biopharmaceutical companies, contract research organizations, diagnostic laboratories, and hospitals each apply different standards for validation, throughput, and cost control, and diagnostic laboratories in particular subdivide into clinical chemistry, hematology, microbiology, and molecular diagnostics, each with its own handling requirements.

Application-level distinctions between diagnostics, drug discovery and development, genomics, and proteomics direct investments toward tailored solutions; diagnostics further differentiates along laboratory diagnostics and point-of-care pathways, where portability and stability become pivotal. Sample type considerations, encompassing blood, cells, tissue, and urine, impose varying constraints on collection devices, preservatives, storage temperatures, and transport logistics. Finally, the workflow segmentation across analysis, collection, processing, storage, and transport underscores the need for interoperable solutions that preserve pre-analytical integrity. These overlapping segmentations demonstrate that decisions about product selection and process design must be made in the context of specific end-use cases and operational constraints to achieve both scientific rigor and economic efficiency.

Explaining how regional regulatory regimes, manufacturing capacity, and logistical infrastructure create differentiated opportunities across the Americas, EMEA, and Asia-Pacific

Regional dynamics are shaping strategic choices in sample handling as organizations weigh local regulatory frameworks, manufacturing footprints, and logistical infrastructure. In the Americas, demand patterns reflect a broad mix of high-throughput clinical laboratories, translational research centers, and biopharmaceutical R&D hubs that prioritize automation, long-term supplier relationships, and rapid access to novel reagents. Supply chain integration and the presence of large contract service providers further influence vendor selection and preferred commercial models.

Across Europe, Middle East & Africa, the landscape is heterogeneous: robust regulatory regimes and centralized healthcare systems in several European markets drive strong emphasis on compliance and validated cold chain capabilities, while emerging markets within the region often focus on affordability, reagent stability at ambient temperatures, and solutions that enable decentralized testing. In Asia-Pacific, rapid investment in genomic and proteomic research, coupled with growing domestic manufacturing capacity, is accelerating adoption of both high-end instruments and localized consumable production. Collectively, these regional differences underscore the importance of tailoring go-to-market strategies, regulatory engagement, and supply chain architecture to local conditions rather than pursuing a uniform global approach.

Identifying competitive differentiators among suppliers that combine validated product portfolios, service models, and interoperability to reduce pre-analytical variability

Competitive dynamics in the sample handling ecosystem are increasingly defined by the ability of organizations to offer integrated value propositions that span hardware, consumables, reagents, and data services. Suppliers that combine robust quality systems, regulatory support, and clear documentation for validation typically gain preference among regulated end users, while those with modular, interoperable platforms appeal to high-throughput research and industrial customers. Companies that invest in application-specific kits and reagents, along with validated protocols, reduce adoption friction and improve customer retention, particularly in diagnostic pathways and regulated drug development workflows.

Service-oriented business models, including instrument-as-a-service, reagent subscription programs, and remote monitoring, are emerging as differentiators that lower upfront capital barriers and provide predictable operational expenditure profiles. Strategic partnerships between instrument manufacturers and reagent suppliers, as well as collaborations with informatics vendors, are enabling more complete solutions that address pre-analytical variability. For procurement leaders, preferred suppliers are those that combine technical reliability, transparent quality practices, and agility in adapting to localized compliance requirements and logistical constraints.

Actionable recommendations for leaders to strengthen supply resilience, standardize validation, and scale automation to reduce pre-analytical risk and operational exposure

Industry leaders can take immediate, actionable steps to fortify sample handling operations by aligning procurement strategy, validation planning, and cross-functional governance. First, embed rigorous supplier qualification processes that evaluate documentation for lot-to-lot consistency, stability data for reagents, and traceability for consumables, while ensuring that contracts address tariff and logistics risks. Second, prioritize investments in automation where it demonstrably reduces manual error and enables consistent throughput; pair these investments with training programs that equip laboratory staff to operate and maintain automated systems effectively.

Third, adopt a risk-based approach to inventory and sourcing that blends regional supplier diversification with strategic onshore or nearshore partnerships to mitigate tariff exposure and lead time variability. Fourth, integrate environmental and chain-of-custody monitoring into laboratory informatics to provide real-time visibility into storage and transport conditions, supporting faster corrective actions and audit readiness. Finally, cultivate cross-functional steering committees composed of procurement, quality, laboratory operations, and R&D to oversee validation protocols, change controls, and supplier performance metrics. These measures collectively improve sample integrity, reduce operational disruptions, and create clearer pathways for scaling scientific operations responsibly.

Explaining a rigorous mixed-methods research methodology that integrates primary interviews, technical literature review, and expert validation to ensure actionable and accurate findings

The research approach combines structured primary engagement with targeted secondary analysis to produce a robust, evidence-based assessment of biological sample handling dynamics. Primary inputs include interviews with laboratory directors, procurement leads, quality assurance professionals, and supply chain managers to capture firsthand perspectives on pain points, adoption drivers, and validation hurdles. These conversations are framed to elicit operational details such as workflow bottlenecks, reagent stability concerns, and instrumentation uptime priorities while ensuring anonymity and confidentiality to promote candid responses.

Secondary research involves systematic review of technical literature, regulatory guidance, product documentation, and case studies to triangulate findings and test hypothesis robustness. Data synthesis emphasizes cross-validation across sources and stress-tests scenario assumptions to identify risks and opportunity levers. Where applicable, expert panels composed of experienced laboratorians and industry technologists review drafts to ensure practical relevance and technical accuracy. Finally, the methodology applies rigorous quality checks for internal consistency, logical coherence, and alignment with the latest published standards to ensure that conclusions are actionable and reflective of current operational realities.

Concluding with a clear synthesis of how coordinated investments in automation, validated reagents, and resilient sourcing secure sample integrity and operational continuity

In summary, the biological sample handling domain is at an inflection point where technological innovation, regulatory scrutiny, and supply chain dynamics converge to redefine how laboratories protect sample integrity and accelerate discovery. Organizations that proactively invest in interoperable automation, validated reagent systems, and real-time chain-of-custody monitoring will be better positioned to manage pre-analytical variability and compliance obligations. Equally important is the strategic reorientation of sourcing practices in light of tariff pressures and logistics uncertainties, which favors diversified supplier portfolios and stronger regional partnerships.

Taken together, these developments imply that operational excellence in sample handling is achieved not by isolated purchases but by coordinated programs that align procurement, quality, and laboratory operations around shared performance metrics. Leadership that fosters cross-functional governance, invests in staff capability, and prioritizes modular, validated solutions will capture the dual benefits of scientific reproducibility and operational resilience. The conclusion underscores the urgency for stakeholders to translate these insights into prioritized actions that protect scientific output and sustain organizational momentum.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of single-use bioprocessing technologies to minimize cross-contamination in biologics manufacturing
  • 5.2. Implementation of IoT-enabled cold chain monitoring devices for real-time sample integrity tracking across supply chains
  • 5.3. Expansion of decentralized point-of-care testing requiring robust sample stabilization and transport solutions
  • 5.4. Development of cryogenic sample preservation methods leveraging novel cryoprotectants to improve long-term viability
  • 5.5. Growth of laboratory automation platforms integrating AI-driven quality control for sample handling and data management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Sample Handling Market, by Product Type

  • 8.1. Consumables
  • 8.2. Instruments
    • 8.2.1. Automated Pipetting Systems
    • 8.2.2. Temperature Controlled Centrifuges
    • 8.2.3. Vortex Mixers
  • 8.3. Reagents And Kits
    • 8.3.1. Antibodies
    • 8.3.2. Buffers And Solutions
    • 8.3.3. Enzymes
    • 8.3.4. Labeling And Detection Reagents
  • 8.4. Software And Services

9. Biological Sample Handling Market, by End User

  • 9.1. Academic And Research Institutes
  • 9.2. Biopharmaceutical Companies
  • 9.3. Contract Research Organizations
  • 9.4. Diagnostic Laboratories
    • 9.4.1. Clinical Chemistry
    • 9.4.2. Hematology
    • 9.4.3. Microbiology
    • 9.4.4. Molecular Diagnostics
  • 9.5. Hospitals

10. Biological Sample Handling Market, by Application

  • 10.1. Diagnostics
    • 10.1.1. Laboratory Diagnostics
    • 10.1.2. Point Of Care
  • 10.2. Drug Discovery And Development
  • 10.3. Genomics
  • 10.4. Proteomics

11. Biological Sample Handling Market, by Sample Type

  • 11.1. Blood
  • 11.2. Cells
  • 11.3. Tissue
  • 11.4. Urine

12. Biological Sample Handling Market, by Workflow

  • 12.1. Analysis
  • 12.2. Collection
  • 12.3. Processing
  • 12.4. Storage
  • 12.5. Transport

13. Biological Sample Handling Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biological Sample Handling Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Sample Handling Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Danaher Corporation
    • 16.3.3. Merck KGaA
    • 16.3.4. Agilent Technologies, Inc.
    • 16.3.5. Avantor, Inc.
    • 16.3.6. Bio-Rad Laboratories, Inc.
    • 16.3.7. PerkinElmer, Inc.
    • 16.3.8. Sartorius AG
    • 16.3.9. QIAGEN N.V.
    • 16.3.10. General Electric Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAMPLE HANDLING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MI